Free Trial

Ovid Therapeutics (OVID) Institutional Ownership

Ovid Therapeutics logo
$1.26 +0.01 (+0.80%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$1.27 +0.01 (+1.19%)
As of 09/12/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Ovid Therapeutics (NASDAQ:OVID)

Current
Institutional Ownership
Percentage
72.24%
Number of
Institutional Buyers
(last 12 months)
27
Total
Institutional Inflows
(last 12 months)
$10.67M
Number of
Institutional Sellers
(last 12 months)
12
Total
Institutional Outflows
(last 12 months)
$2.79M
Get OVID Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ovid Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

OVID Institutional Buying and Selling by Quarter

Ovid Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Rosalind Advisors Inc.500,000$165K0.1%N/A0.703%
8/15/2025 Rubric Capital Management LP478,533$158K0.0%-91.0%0.673%
8/14/2025 Jane Street Group LLC142,597$47K0.0%N/A0.201%
8/14/2025 Velan Capital Investment Management LP160,000$53K0.1%+64.9%0.225%
8/13/2025 Marshall Wace LLP164,721$54K0.0%N/A0.232%
8/13/2025 Kennedy Capital Management LLC1,502,329$496K0.0%-13.3%2.113%
8/8/2025 Geode Capital Management LLC643,335$212K0.0%-51.7%0.905%
8/1/2025 Y Intercept Hong Kong Ltd160,306$53K0.0%N/A0.225%
7/11/2025 Assenagon Asset Management S.A.435,620$144K0.0%-22.3%0.613%
6/27/2025 Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%
5/21/2025Acadian Asset Management LLC2,088,046$650K0.0%+12.8%2.936%
5/16/2025Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%
5/16/2025Jacobs Levy Equity Management Inc.200,593$63K0.0%-31.2%0.282%
5/16/2025Adage Capital Partners GP L.L.C.1,150,000$359K0.0%+15.0%1.617%
5/14/2025Affinity Asset Advisors LLC667,516$208K0.0%N/A0.939%
5/12/2025Nuveen LLC119,113$37K0.0%N/A0.168%
5/8/2025XTX Topco Ltd93,154$29K0.0%N/A0.131%
4/15/2025Assenagon Asset Management S.A.560,830$175K0.0%+699.9%0.789%
2/17/2025Velan Capital Investment Management LP70,000$65K0.1%N/A0.099%
2/17/2025Madison Avenue Partners LP3,722,627$3.48M0.4%-9.6%5.242%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC943,416$881K0.1%+50.2%1.329%
2/17/2025Jacobs Levy Equity Management Inc.291,701$272K0.0%N/A0.411%
2/17/2025Bridgeway Capital Management LLC229,115$214K0.0%-26.0%0.323%
2/17/2025Bank of America Corp DE56,733$53K0.0%+49.7%0.080%
2/17/2025BNP Paribas Financial Markets104,712$98K0.0%-52.5%0.147%
2/14/2025Adage Capital Partners GP L.L.C.1,000,000$934K0.0%N/A1.408%
2/13/2025Kennedy Capital Management LLC1,545,387$1.44M0.0%+1.1%2.176%
2/13/2025Renaissance Technologies LLC107,700$101K0.0%+142.0%0.152%
2/13/2025ADAR1 Capital Management LLC130,532$122K0.0%+245.8%0.184%
2/12/2025TLS Advisors LLC680,967$636K1.5%-11.7%0.959%
2/12/2025Takeda Pharmaceutical Co. Ltd.7,531,996$7.01M26.4%N/A10.607%
2/12/2025JPMorgan Chase & Co.1,418,306$1.32M0.0%-3.1%1.997%
2/10/2025Monimus Capital Management LP138,266$129K0.1%N/A0.195%
1/30/2025Rhumbline Advisers84,078$79K0.0%+22.3%0.118%
1/17/2025SG Americas Securities LLC37,636$35K0.0%+83.9%0.053%
1/14/2025Assenagon Asset Management S.A.70,114$65K0.0%-18.7%0.099%
11/19/2024Barclays PLC84,175$98K0.0%+311.2%0.119%
11/16/2024Geode Capital Management LLC1,317,330$1.56M0.0%+1.1%1.855%
11/15/2024Barclays PLC84,175$98K0.0%+311.2%0.119%
11/15/2024XTX Topco Ltd38,230$45K0.0%+46.2%0.054%
11/15/2024Jane Street Group LLC38,399$45K0.0%-61.1%0.054%
11/14/2024Verition Fund Management LLC74,875$88K0.0%N/A0.105%
11/13/2024BNP Paribas Financial Markets220,401$260K0.0%+4,128.7%0.311%
11/13/2024FMR LLC50,225$59K0.0%+1,907.4%0.071%
11/5/2024GSA Capital Partners LLP260,509$307K0.0%+118.0%0.367%
10/23/2024Assenagon Asset Management S.A.86,289$102K0.0%N/A0.122%
8/16/2024Driehaus Capital Management LLC1,400,191$1.08M0.0%N/A1.974%
8/13/2024DCF Advisers LLC41,750$32K0.0%+111.6%0.059%
8/9/2024Renaissance Technologies LLC141,200$109K0.0%-9.9%0.199%
8/9/2024Dimensional Fund Advisors LP274,982$211K0.0%-19.6%0.388%
8/1/2024Rhumbline Advisers69,733$54K0.0%-15.6%0.098%
8/1/2024FFT Wealth Management LLC489,552$377K0.0%+18.2%0.690%
7/26/2024Bank of New York Mellon Corp218,163$168K0.0%-5.0%0.308%
5/16/2024BVF Inc. IL3,853,818$11.75M0.3%-43.7%5.442%
5/15/2024Price T Rowe Associates Inc. MD17,396$54K0.0%+22.1%0.025%
5/10/2024Vanguard Group Inc.2,976,308$9.08M0.0%-0.5%4.203%
5/7/2024SG Americas Securities LLC35,938$110K0.0%-9.7%0.051%
5/7/2024Empowered Funds LLC128,070$391K0.0%+8.1%0.181%
5/1/2024BNP Paribas Financial Markets32,162$98K0.0%+74.7%0.045%
4/29/2024China Universal Asset Management Co. Ltd.13,579$41K0.0%+66.0%0.019%
4/24/2024Assenagon Asset Management S.A.114,265$349K0.0%+45.6%0.162%
2/14/2024Rubric Capital Management LP5,315,969$17.12M0.4%-2.4%7.521%
2/14/2024Vestal Point Capital LP85,429$275K0.0%N/A0.121%
2/13/2024DCF Advisers LLC18,730$60K0.0%-38.4%0.026%
2/6/2024FFT Wealth Management LLC395,774$1.27M0.1%N/A0.560%
1/24/2024China Universal Asset Management Co. Ltd.8,178$26K0.0%N/A0.012%
1/17/2024Assenagon Asset Management S.A.78,479$253K0.0%N/A0.111%
1/12/2024SG Americas Securities LLC39,792$128K0.0%+52.7%0.056%
11/13/2023Connor Clark & Lunn Investment Management Ltd.81,173$312K0.0%+17.2%0.115%
11/13/2023Acadian Asset Management LLC1,701,228$6.53M0.0%-4.5%2.407%
11/7/2023New York State Common Retirement Fund19,110$73K0.0%-28.7%0.027%
11/7/2023Jump Financial LLC15,811$61K0.0%N/A0.022%
10/13/2023SG Americas Securities LLC26,064$100K0.0%N/A0.037%
9/21/2023Barclays PLC11,955$40K0.0%N/A0.017%
8/11/2023Rubric Capital Management LP5,445,910$17.86M0.8%-22.2%7.714%
8/11/2023Tejara Capital Ltd112,591$369K0.2%-5.2%0.159%
8/9/2023DCF Advisers LLC64,764$212K0.1%-5.1%0.092%
8/4/2023American International Group Inc.28,701$94K0.0%N/A0.041%
7/27/2023EA Series Trust98,952$325K0.0%N/A0.140%
7/25/2023Raymond James & Associates25,000$82K0.0%N/A0.035%
5/15/2023Madison Avenue Partners LP3,104,603$8.01M1.7%+14.1%4.402%
5/15/2023Rubric Capital Management LP7,001,124$18.06M0.5%+2.5%9.928%
5/12/2023Tejara Capital Ltd118,791$306K0.2%+10.5%0.168%
5/11/2023Acadian Asset Management LLC1,780,873$4.59M0.0%-1.9%2.525%
5/10/2023Connor Clark & Lunn Investment Management Ltd.30,858$80K0.0%-22.7%0.044%
5/9/2023Y Intercept Hong Kong Ltd35,116$91K0.0%N/A0.050%
5/1/2023Virtu Financial LLC17,892$46K0.0%N/A0.025%
2/10/2023Blair William & Co. IL24,328$45K0.0%-22.1%0.035%
11/14/2022Rubric Capital Management LP4,516,300$8.31M0.4%+56.7%6.409%
11/10/2022Stonepine Capital Management LLC1,540,671$2.84M1.3%-55.8%2.188%
10/18/2022Newman Dignan & Sheerar Inc.15,522$29K0.0%N/A0.022%
8/16/2022Driehaus Capital Management LLC1,343,325$2.89M0.0%+273.2%1.908%
8/12/2022Ikarian Capital LLC26,831$59K0.0%-96.4%0.038%
8/5/2022Connor Clark & Lunn Investment Management Ltd.36,748$79K0.0%-57.7%0.052%
7/29/2022Walker Asset Management LLC43,400$105K0.0%N/A0.062%
7/29/2022Russell Investments Group Ltd.267,868$574K0.0%-2.9%0.380%
7/27/2022Assenagon Asset Management S.A.26,362$57K0.0%N/A0.037%
7/25/2022Walker Asset Management LLC43,400$105K0.0%N/A0.062%
5/12/2022Acadian Asset Management LLC2,139,290$6.72M0.0%+4.9%3.038%
5/12/2022Connor Clark & Lunn Investment Management Ltd.86,888$273K0.0%-27.3%0.123%
(Data available from 1/1/2016 forward)

OVID Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of OVID shares?

During the previous two years, 47 institutional investors and hedge funds held shares of Ovid Therapeutics. The most heavily invested institutionals were BVF Inc. IL ($11.75M), Vanguard Group Inc. ($9.08M), Takeda Pharmaceutical Co. Ltd. ($7.01M), Madison Avenue Partners LP ($3.48M), JPMorgan Chase & Co. ($1.32M), Driehaus Capital Management LLC ($1.08M), and OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC ($881K).Learn more on Ovid Therapeutics' institutional investors.

What percentage of Ovid Therapeutics' stock is owned by institutional investors?

72.24% of Ovid Therapeutics' stock is owned by institutional investors. Learn more on OVID's institutional investor holdings.

Which institutional investors have been buying Ovid Therapeutics' stock?

Of the 36 institutional investors that purchased Ovid Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Takeda Pharmaceutical Co. Ltd. ($7.53M), Driehaus Capital Management LLC ($1.40M), Adage Capital Partners GP L.L.C. ($1.15M), Assenagon Asset Management S.A. ($691.27K), Affinity Asset Advisors LLC ($667.52K), Rosalind Advisors Inc. ($500K), and FFT Wealth Management LLC ($471.30K).

How much institutional buying is happening at Ovid Therapeutics?

Institutional investors have bought a total of 13,079,790 shares in the last 24 months. This purchase volume represents approximately $10.67M in transactions.

Which of Ovid Therapeutics' major shareholders have been selling company stock?

Of the 12 institutional investors that sold Ovid Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Rubric Capital Management LP ($4.84M), Geode Capital Management LLC ($687.66K), Madison Avenue Partners LP ($394.15K), Kennedy Capital Management LLC ($230.54K), Goldman Sachs Group Inc. ($187.38K), Assenagon Asset Management S.A. ($141.39K), and BNP Paribas Financial Markets ($115.69K).

How much institutional selling is happening at Ovid Therapeutics?

Institutional investors have sold a total of 6,962,046 shares in the last 24 months. This volume of shares sold represents approximately $2.79M in transactions.



This page (NASDAQ:OVID) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners